Evaluating the Effect Of Rifaximin on the Gut Microbiota and Metabolome in SIBO Using CapScan®

Exclusion Criteria

• •History of any of the following: Prior gastric or esophageal surgery, including lap banding or bariatric surgery, bowel obstruction, gastric outlet obstruction, diverticulitis, inflammatory bowel disease, ileostomy or colostomy, gastric or esophageal cancer, achalasia, esophageal diverticulum, active dysphagia or odynophagia.
• •Actively taking a proton-pump-inhibitor medication within 30 days of enrollment
• •Pregnancy or planned pregnancy within 30 days from Screening Visit, or breast-feeding
• •Any form of active substance abuse or dependence (including drug or alcohol abuse), unstable medical or psychiatric disorder, or any chronic condition susceptible, in the opinion of the investigator, to interfere with the conduct of the study
• •A clinical condition that, in the judgment of the investigator, could potentially pose a health risk to the subject while involved in the study